188 related articles for article (PubMed ID: 25770134)
1. Ranolazine reduces remodeling of the right ventricle and provoked arrhythmias in rats with pulmonary hypertension.
Liles JT; Hoyer K; Oliver J; Chi L; Dhalla AK; Belardinelli L
J Pharmacol Exp Ther; 2015 Jun; 353(3):480-9. PubMed ID: 25770134
[TBL] [Abstract][Full Text] [Related]
2. Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment.
Lee JC; Kim KC; Choe SY; Hong YM
Anat Cell Biol; 2016 Mar; 49(1):7-14. PubMed ID: 27051563
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension.
Tanaka Y; Takase B; Yao T; Ishihara M
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):426-36. PubMed ID: 23600532
[TBL] [Abstract][Full Text] [Related]
5. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
6. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
Bogaard HJ; Natarajan R; Mizuno S; Abbate A; Chang PJ; Chau VQ; Hoke NN; Kraskauskas D; Kasper M; Salloum FN; Voelkel NF
Am J Respir Crit Care Med; 2010 Sep; 182(5):652-60. PubMed ID: 20508210
[TBL] [Abstract][Full Text] [Related]
8. Right predominant electrical remodeling in a pure model of pulmonary hypertension promotes reentrant arrhythmias.
Strauss B; Bisserier M; Obus E; Katz MG; Fargnoli A; Cacheux M; Akar JG; Hummel JP; Hadri L; Sassi Y; Akar FG
Heart Rhythm; 2022 Jan; 19(1):113-124. PubMed ID: 34563688
[TBL] [Abstract][Full Text] [Related]
9. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S
Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668
[TBL] [Abstract][Full Text] [Related]
10. Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest.
Fumagalli F; Russo I; Staszewsky L; Li Y; Letizia T; Masson S; Novelli D; Rocchetti M; Canovi M; Veglianese P; Gobbi M; Latini R; Zaza A; Ristagno G
Heart Rhythm; 2014 Sep; 11(9):1641-7. PubMed ID: 24858811
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor improves right ventricular remodeling in pulmonary arterial hypertensive rats via decreasing neurohormonal activation and inhibiting apoptosis.
Wang X; Wang Y; Rong S; Ma H; Ma Q; Zhao J
Chin Med J (Engl); 2014; 127(10):1924-30. PubMed ID: 24824257
[TBL] [Abstract][Full Text] [Related]
12. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
[TBL] [Abstract][Full Text] [Related]
13. [Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats].
Li XW; Guo B; Shen YY; Yang JR
Yao Xue Xue Bao; 2015 Sep; 50(9):1128-34. PubMed ID: 26757549
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
[TBL] [Abstract][Full Text] [Related]
15. Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.
Sugiyama A; Kaisho M; Okada M; Otani K; Yamawaki H
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947968
[TBL] [Abstract][Full Text] [Related]
16. Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
Wu J; Liu T; Shi S; Fan Z; Hiram R; Xiong F; Cui B; Su X; Chang R; Zhang W; Yan M; Tang Y; Huang H; Wu G; Huang C
Cardiovasc Diabetol; 2022 Sep; 21(1):197. PubMed ID: 36171554
[TBL] [Abstract][Full Text] [Related]
17. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
18. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
[TBL] [Abstract][Full Text] [Related]
19. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process.
Angelini A; Castellani C; Ravara B; Franzin C; Pozzobon M; Tavano R; Libera LD; Papini E; Vettor R; De Coppi P; Thiene G; Vescovo G
J Heart Lung Transplant; 2011 Nov; 30(11):1281-93. PubMed ID: 21989772
[TBL] [Abstract][Full Text] [Related]
20. [Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression].
Wang X; Wang Y; Rong S; Ma H
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):427-32. PubMed ID: 25200042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
